Global Medical Ultrasonic Hemostatic Knife Market - 2024-2031

The global medical ultrasonic hemostatic knife market reached US$ 1.5 billion in 2023 and is expected to reach US$ 2.5 billion by 2031, growing at a CAGR of 6.9% during the forecast period 2024-2031.

The medical ultrasonic hemostatic knife is a surgical tool that uses ultrasonic energy to combine cutting and coagulation capabilities. It offers precision, reduced thermal damage, and effective hemostasis. The knife operates by converting electrical energy into mechanical vibrations, which create a cavitation effect when the vibrating tip contacts tissue. This creates tiny bubbles, separating tissue cells with minimal damage to surrounding structures. The frictional heat produced by the ultrasonic vibrations denatures proteins like collagen and fibrin, forming a coagulum that seals blood vessels at low temperatures, reducing thermal injury compared to traditional methods like electrosurgery.

Market Dynamics: Drivers & Restraints

Growing Demand For Advanced Surgical Tools

The lucrative fervor for enhanced surgical sharpness, higher efficiency, and increased patient safety is driving the hemostatic knife market of ultrasound globally. The device accomplishes tissue cutting and coagulation, resulting in minimal blood loss and thermal injury making it easier to work in minimal access surgery. The increasing incidence of chronic diseases that include cancer, cardiovascular disorders, and obesity is moving hospitals and other surgical institutes towards adoption of ultrasonic hemostatic knives. Technologies are making the application of different types and specialities such as strong light, compact design, new energy delivery systems, and robotic surgical platforms more promising. The bustling development of healthcare infrastructure in developing economies coupled with an increasing emphasis on advanced surgical technology continues to spur the demand for the market.

For instance, Ethicon HARMONIC ACE+7 , The HARMONIC ACE+7 Shears with Adaptive Tissue Technology is designed to enhance surgical precision and performance. The HARMONIC ACE+7 Shears is a sterile, energy-efficient ultrasonic instrument used for general dissection, vessel sealing, back-scoring, otomy creation, and mesentery marching. It features an ergonomic handle, hand piece attachment, Advanced Hemostasis with two energy delivery buttons, and three shaft lengths (20cm, 36cm, and 45cm).

One of the study publsihed in NCBI that focuses on the duration, activation times, cutting speed, visibility, blade stickiness, and lens cleansing times of an omentectomy using devices from Harmonic, Ethicon Endo-Surgery Inc., Sonicision, Medtronic, and Medisonic. The devices were used to divide the 4 major gastric arteries, with 10 patients per device.

Stringent Regulatory Requirements

Ultrasonic surgical devices face significant market restraint due to stringent regulatory environments, including extensive clinical trials and compliance requirements from regulatory bodies like the FDA and EMA. This delays product launches and increases development costs for manufacturers. These hurdles, potential device malfunction risks, and the need for continuous updates pose challenges to manufacturers and could slow market growth.

Ultrasonic hemostatic devices in the U.S. typically fall under Class II or III classifications, requiring a 510(k) premarket notification or a more rigorous Premarket Approval (PMA) process. The 510(k) process requires demonstrating substantial equivalence to existing devices, which can be complex due to varying interpretations. In China, the NMPA's Medical Device Classification Catalogue has reclassified certain ultrasonic surgical devices from Class II to Class III, causing stricter regulatory scrutiny and potentially higher costs for clinical trials and registration processes.

Segment Analysis

The global medical ultrasonic hemostatic knife market is segmented based on product type, type, application, end user and region.

Product Type:

Handheld ultrasonic hemostatic knives segment is expected to dominate the medical ultrasonic hemostatic knife market share

The handheld ultrasonic hemostatic knives segment holds a major portion of the medical ultrasonic hemostatic knife market share and is expected to continue to hold a significant portion of the medical ultrasonic hemostatic knife market share during the forecast period.

Handheld ultrasonic hemostatic knives, better known as ultrasonic scalpels, comprise a very important modern surgery technology, offering precise cutting with effective hemostatic characteristics while minimizing injuries to surrounding tissues. These devices further impart ultrasound-induced high-frequency vibration on biological tissues to produce effects of cavitation for both cutting and coagulation at the same time. Comparatively, bleeding is reduced, and so is thermal damage when these devices are compared to conventional surgical instruments. Reduced thermal damage, effective hemostasis, efficiency in surgery, duration of operation, and then the recovery of patients are some of the key advantages.

The global market for ultrasonic hemostatic knives has witnessed growth on account of the rapid demand for minimally invasive surgeries and technology that offers diversified applications across surgeries. North America holds around 92% of this market because of the highly developed healthcare infrastructure and fast adoption of the latest innovative surgical technologies. However, countries in the Asia-Pacific region, such as South Korea and China, have also been rapidly developing owing to their increased healthcare investments and growing number of surgical procedures. Meanwhile, Europe is also increasing its market, mainly by advanced medical devices for improved surgical outcomes.

Application:

General surgery segment is the fastest-growing segment in the medical ultrasonic hemostatic knife market share

The general surgery segment is the fastest-growing segment in the medical ultrasonic hemostatic knife market share and is expected to hold the market share over the forecast period.

General surgery is expected to be a fast growing application in the market for medical ultrasonic hemostatic knives of the world as these knives are being used more and more in various surgical procedures for better results. These knives can serve well in almost all laparoscopic and open surgeries and allow exactly targeted tissue dissection and optimal hemostasis with little blood loss. It has further benefits for thermal damage and operative time and is therefore an inevitable part of complex surgeries such as gastrointestinal, hepatobiliary, and colorectal surgeries. An increasing number of conditions such as hernias, appendicitis, and gallbladder diseases have made such developments more common. Advancements in ultrasonic technology and minimally invasive surgical techniques contribute to the increasing popularity of these knives among general surgeons worldwide.

Geographical Analysis

North America is expected to hold a significant position in the medical ultrasonic hemostatic knife market share

North America holds a substantial position in the medical ultrasonic hemostatic knife market and is expected to hold most of the market share due to technological developments in them, increased surgical volumes, and preference toward minimally invasive techniques. The advancement in technology has resulted in more efficient hemostatic knives that are also user-friendly for better precision and safety in surgery. There are many surgical procedures demanded due to the aging population along with chronic diseases, including cancer, cardiovascular, and other conditions among individuals.

Moreover, solid healthcare infrastructure in North America, with high healthcare spending, promotes the taking up of cutting-edge medical techniques in practice. Adoption of advanced surgical techniques, thus, is promoted by the value-based healthcare transition as it drives a shift toward operational efficiency and satisfaction among patients. The market for ultrasonic cutting hemostatic knives in North America is dynamic in composition emerging from interplay among technological innovation, clinical adoption rates, regulatory oversight, and competitive forces in the market.

Thus, stakeholders are encouraged to direct their focus toward product development and clinical evidence generation. With the continued evolution of the abovementioned factors, the projected view indicates that the North American region will remain world's leader in the ultrasonic hemostatic knife market.

Europe is growing at the fastest pace in the medical ultrasonic hemostatic knife market

Europe holds the fastest pace in the medical ultrasonic hemostatic knife market and is expected to hold most of the market share due to the its established healthcare systems and focus on advanced surgical techniques. The aging population and rising prevalence of chronic conditions like cancer, cardiovascular diseases, and gastrointestinal disorders have increased demand for precise and efficient surgical tools. Governments and healthcare organizations emphasize minimally invasive procedures to improve patient outcomes and reduce costs. Technological advancements, such as ergonomic designs and energy delivery systems, support market growth. Leading manufacturers, extensive R&D activities, and favourable regulatory frameworks ensure a steady supply of innovative products.

Competitive Landscape

The major global players in the medical ultrasonic hemostatic knife market include Ethicon, Inc. (Johnson & Johnson), Medtronic plc, Stryker Corporation, Olympus Corporation,Boston Scientific Corporation, Smith & Nephew plc, B. Braun Melsungen AG, CONMED Corporation, Aesculap, Inc. (B. Braun), Erbe Elektromedizin GmbH among others.

Emerging Players

The emerging players in the medical ultrasonic hemostatic knife market include Advanced Medical Technologies, Inc, InnoSound Technologies , ZUDEN Technology Co., Ltd and among others.

Key Developments

• In August 2023, The Heal Force UHSIOO Ultrasonic Scalpel System launched, revolutionizing surgical procedures with its advanced technology. The UHSI 00 Ultrasonic Soft Tissue Cutting knife and Hemostasis System provides surgeons with unparalleled control and accuracy, offering a stable power host machine and a specially coated cutter head. This innovative system helps doctors solve various tissue processing challenges during surgery, paving the way for a new era of precision and efficiency.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical ultrasonic hemostatic knife market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.